Literature DB >> 18331570

The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies.

Franco Rongioletti1, James W Patterson, Alfredo Rebora.   

Abstract

The dermatological disorders associated with monoclonal gammopathies are clinically heterogeneous and may be divided into four groups with distinctive pathogenetic mechanisms (a) specific (infiltrative) disorders including primary and secondary cutaneous plasmacytoma and cutaneous lymphoplasmacytic infiltration of Waldenström's disease (b) skin disorders because of the deposition of monoclonal immunoglobulin (M protein), including amyloidoisis macroglobulinemia cutis, light chain deposition of Randall's disease, follicular spicules of the nose, and cryoglobulinemia (c) skin disorders associated with monoclonal gammopathies, including highly associated (>50%), weakly associated (<50%) or anecdotal and (d) miscellaneous (non specific). In most cases, histopathology is crucial to confirm or to diagnose those skin conditions and is also very useful to understand their pathogenetic mechanisms.

Entities:  

Mesh:

Year:  2008        PMID: 18331570     DOI: 10.1111/j.1600-0560.2007.00884.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  7 in total

1.  M protein deposition in the skin: a rare manifestation of Waldenström macroglobulinemia.

Authors:  Barbara Oberschmid; Udo Siebolts; Dirk Mechtel; Ute Kreibich; Alexandra Beller; Claudia Wickenhauser
Journal:  Int J Hematol       Date:  2011-03-08       Impact factor: 2.490

2.  IgM Plasma Cells Reside in Healthy Skin and Accumulate with Chronic Inflammation.

Authors:  R Paul Wilson; Shannon E McGettigan; Van Duc Dang; Anil Kumar; Michael P Cancro; Neda Nikbakht; William Stohl; Gudrun F Debes
Journal:  J Invest Dermatol       Date:  2019-05-30       Impact factor: 8.551

3.  IgA pemphigus associated with monoclonal gammopathy completely resolved after achievement of complete remission of multiple myeloma with bortezomib, cyclophosphamide and dexamethasone regimen.

Authors:  Zdenek Adam; Marta Krejcí; Ludek Pour; Josef Feit; Tomás Büchler; Roman Hájek
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

4.  Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.

Authors:  Julie Delyon; Maud Bézier; Michel Rybojad; Josette Brière; Pierre Validire; Martine Bagot; Anne Janin; Maxime Battistella
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

5.  Pyoderma gangrenosum with monoclonal IgA gammopathy and pulmonary tuberculosis. Illustrative case and review.

Authors:  Krystyna Romańska-Gocka; Czanita Cieścińska; Barbara Zegarska; Robert A Schwartz; Jakub Cieściński; Dorota Olszewska-Słonina; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

6.  Skin dissemination of myeloma.

Authors:  Kaja Męcińska-Jundziłł; Agnieszka Białecka; Urszula Adamska; Adam Cichewicz; Anna Skórczewska; Jacenty Szukalski; Jarosław Czyż; Arkadiusz Jundziłł; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

7.  Recurrent Sweet's syndrome in a patient with multiple myeloma.

Authors:  Carmelo Gurnari; Luca Franceschini; Lucia Anemona; Francesca Passarelli; Sara Vaccarini; Livio Pupo; Ida Provenzano; Daniela Nasso; Manuela Rizzo; Maria Cantonetti
Journal:  Clin Case Rep       Date:  2018-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.